Cargando…
Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives
Nucleic acid-based aptamers have emerged as efficient delivery carriers of therapeutics. Thanks to their unique features, they can be, to date, considered one of the best targeting moieties, allowing the specific recognition of diseased cells and avoiding unwanted off-target effects on healthy tissu...
Autores principales: | Esposito, Carla Lucia, Catuogno, Silvia, Condorelli, Gerolama, Ungaro, Paola, de Franciscis, Vittorio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266988/ https://www.ncbi.nlm.nih.gov/pubmed/30384431 http://dx.doi.org/10.3390/genes9110529 |
Ejemplares similares
-
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
por: Esposito, Carla Lucia, et al.
Publicado: (2017) -
Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option
por: Catuogno, Silvia, et al.
Publicado: (2018) -
Aptamer-Mediated Targeted Delivery of Therapeutics: An Update
por: Catuogno, Silvia, et al.
Publicado: (2016) -
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells
por: Esposito, Carla Lucia, et al.
Publicado: (2014) -
Targeting Insulin Receptor with a Novel Internalizing Aptamer
por: Iaboni, Margherita, et al.
Publicado: (2016)